You are here:Home
»
Growth Factors, Cytokines
»
Growth Factors-VEGF
»
Vascular Endothelial Growth Factor, Recombinant, Mouse (VEGF)
Vascular Endothelial Growth Factor, Recombinant, Mouse (VEGF)
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as Tumor Angiogenesis Factor or Vascular Permeability Factor. Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating Vasolidation via nitric oxide-dependent pathways. Alternative splicing of the mRNA for VEGF-A results in several isoforms of the protein being produced. Rat and bovine VEGF are one amino acid shorter than the human factor, and the bovine and human sequences show a homology of 95 percent. In contrast to other factors mitogenic for endothelial cells such as FGF-1 , FGF-2 and PDGF, VEGF is synthesized as a precursor containing a typical hydrophobic secretory signal sequence of 26 amino acids. Glycosylation is not required for efficient secretion of VEGF. | | | Catalog # | V2110-07C | | Description | Recombinant Mouse VEGF produced in Sf9 insect cells is a double, glycosylated, polypeptide chain containing 164 amino acids and having a molecular mass of 38814 Dalton. Recombinant Murine VEGF is purified by proprietary chromatographic techniques. | | Dimers and Aggregates | Less than 1% as determined by silver-stained SDS-PAGE gel analysis. | | Biological Activity | Recombinant Mouse VEGF-Sf9 is fully biologically active when compared to standards. Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-2.0 ng/ml, corresponding to a specific activity of 1 x 106 Units/mg. | | Endotoxin | 0.1ng/ug (IEU/ug) of VEGF-Sf9. | | Protein Content | Protein quantitation was carried out by two independent methods: | | 1. UV spectroscopy at 280 nm. | | 2. Analysis by RP-HPLC, using a calibrated solution of VEGF as a Reference Standard. | | Solubility | It is recommended to reconstitute the lyophilized VEGF-Sf9 in sterile 18M -cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions. | | Stability | Lyophilized Recombinant VEGF-Sf9 although stable at room temperature for 3 weeks, should be stored desiccated below -180C. Upon reconstitution Murine VEGF-Sf9 should be stored at 40C between 2-7 days and for future use below -180C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. | | Molecular Weight | 38.81kD | | Source | Sf9 insect cells | | Purity | 95% as determined by RP-HPLC, anion-exchange FPLC and/or reducing and non-reducing SDS-PAGE Silver Stained gel. | | Concentration | ~1mg/ml | | Form | Supplied as a lyophilized powder without additives. | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
External Links
|
